PERSONALIZED MEDICINE COALITION for PERSONALIZED MEDICINE COALITION
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
FY 2025 Food and Drug Administration Budget Priorities for CDER, CBER and CDRH FY 2025 National Institutes of Health Budget Priorities
| Lobbyist | Covered position, as disclosed |
|---|---|
| CYNTHIA BENS | Staff, Representative Paul E. Kanjorski |
Health Issues HCR
Congressional Personalized Medicine Caucus Right Drug Dose Now Act Oversight of Laboratory Developed Tests AHRQ Draft Report Blood-based Tests for Multiple Cancer Screening: A Systematic Review CMS Implementation of Medicare Drug Price Negotiation Program/ Medicare Drug Price Negotiation Program Medicare and Medicaid Programs; Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly (CMS-4208-P) Standardizing Laboratory Practices in Pharmacogenomics (STRIPE) Collaborative Community
| Lobbyist | Covered position, as disclosed |
|---|---|
| CYNTHIA BENS | Staff, Representative Paul E. Kanjorski |
| DAVID L DAVENPORT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.